Key pharma stocks, including Granules India and Gland Pharma, have shown substantial recovery, with the Nifty Pharma index ...

Axis Securities maintains a 'buy' on Aurobindo Pharma and Lupin, expecting strong performance in the pharmaceutical sector, ...

ITI Pharma and Healthcare Fund - Direct Plan - Rediff Money - India's leading finance site for latest share prices, mutual funds, nifty futures and options, graphs, expert stock Calls and share market ...

JM Value Fund - Rediff Money - India's leading finance site for latest share prices, mutual funds, nifty futures and options, graphs, expert stock Calls and share market updates ...

Aurobindo Pharma Ltd (BOM:524804) reports robust financial performance with significant growth in European and specialty segments, despite challenges in key markets.

Aurobindo Pharma share price declined over 3% on Tuesday after the company reported a fire incident at one of its manufacturing facilities in Andhra Pradesh that resulted in certain ancillary ...

Aurobindo Pharma subsidiary Eugia Pharma Specialities has received final approval from the U.S. Food and Drug Administration (U.S. FDA) to manufacture and market Dasatinib Tablets in different ...

With this, Aurobindo Pharma has now a total of 540 Abbreviated New Drug Application (ANDA ... Aurobindo’s 30 manufacturing and packaging sites have approvals from major global regulatory agencies.

Aurobindo Pharma shares jumped 5 per cent on Friday ... This study is progressing across multiple sites in the EU, focusing on women with postmenopausal osteoporosis, and we anticipate its completion ...

Gland Pharma topped the losses with a drop of almost 6 per cent, followed by Aurobindo Pharma, which fell by almost 5 per cent. Biocon's shares fell more than 4 per cent, and Sun Pharma, Lupin, Laurus ...

The U.S. Food and Drug Administration (U.S. FDA) has classified a warehouse of Aurobindo Pharma subsidiary in New Jersey, U.S. as Official Action Indicated (OAI) after an inspection it conducted.